Brooks Laboratories Limited (NSE:BROOKS)

Market Cap	4.38B
Revenue (ttm)	769.62M
Net Income (ttm)	-181.15M
Shares Out	29.78M
EPS (ttm)	-6.94
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,268
Average Volume	104,829
Open	140.65
Previous Close	140.65
Day's Range	137.50 - 147.68
52-Week Range	73.25 - 198.86
Beta	1.47
RSI	65.24
Earnings Date	May 16, 2025

About Brooks Laboratories

Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. The company offers liquid and dry powder injection, carbapenem dry powder injectables, tablets, oral suspension, dry syrup, and eye/ear drops. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 293
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BROOKS

Financial Performance

In 2023, Brooks Laboratories's revenue was 794.86 million, an increase of 25.76% compared to the previous year's 632.05 million. Losses were -195.92 million, -6.22% less than in 2022.